« Clinton at the Global Changing Diabetes Leadership Forum | Main | John Edwards comparing diabetes and cancer? »


The idea sounds interesting. But until internet security approaches are dramatically improved, I'm not sure I'd want to have my data posted somewhere that I don't have direct control over.

I'd also be concerned with the cost of using this regularly. Loading the data onto your cell phone and then having your phone load the information up on the web seems to exclude a large portion of the potential user base. I'm a self-avowed geek, but I never use my cell phone for internet access. Too slow and too expensive.

I think there are several other holes I could punch in the BodyTel product story. I guess I'll wait and see how it all plays out.

Hmmm, while it sounds like interesting technology, and I like the idea of combining a cell phone with a meter, but you're 100% right about the reasons people do not test (unfortunately, even education doesn't solve the issue in many cases).

A Canadian study done several years ago proved conclusively that when patients did not have to worry about the cost of testing supplies, they not only tested more frequently, but showed a statistically significant reduction in glycosated hemoglobin values (A1c), yet the price tag on testing supplies limits many patients -- especially those paying out-of-pocket, and the perception that a high reading is a bad thing (its not, it provides patients with more information on what they need to do) is widespread and is a huge discouragement for many patients to even bother testing. Yet many doctors and educators fail to help establish the issue that its only a number, but one which helps the patient decide what to do next and in the process, sow the seeds for testing avoidance.

I see the cost of testing supplies as a major impediment to adequate testing, and the corresponding hassle that many patients who are in good control go through with their healthcare providers to get an adequate supplies adds to the problem. Why, for example, are patients who ask for 15 test strips a day hassled about? The issue is that our healthcare system still has a very short-term outlook, and paying today to save money tomorrow is not seen as wise investment, or certainly one that should be questioned.

While GlucoTel positioning itself as the solution to the diabetes epidemic isn't exactly convincing, they are hardly alone in their less-than-truthful jockeying on this issue. We can count Johnson & Johnson, Abbott, Eli Lilly and Company, Novo Nordisk and Sanofi Aventis among the companies that haven't done anything fundamentally new in terms of treatment, yet they all suggest that their companies are "working hard to address the diabetes problem" -- unfortunately, many see them as "hardly working to address the diabetes problem".

The comments to this entry are closed.